| Kerry Larkin is a 5th year PhD candidate in the Department of Cell Biology and is an NIH Ruth L. Kirschstein NRSA F31 predoctoral fellow. Her research investigates the cellular death mechanisms of a chemotherapeutic drug used to treat breast and ovarian cancers. She holds a Bachelor of Arts degree in Biology and Music from the College of the Holy Cross. Kerry has experience preparing fellowship applications and writing about science for a range of audiences. Outside of academics, she enjoys playing music, running, and knitting. |
